FY2025
Effective from
- Code-level rules changed
Drug or chemical induced diabetes mellitus
Category — select a more specific code
CDC/NCHS · FY2025For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2025
Effective from
Drug or chemical induced diabetes mellitus
Category — select a more specific code
CDC/NCHS · FY2025| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Code-level rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Code-level rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Code-level rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E09.0Drug or chemical induced diabetes mellitus with hyperosmolarityCategory · further specificity requiredE09.1Drug or chemical induced diabetes mellitus with ketoacidosisCategory · further specificity requiredE09.2Drug or chemical induced diabetes mellitus with kidney complicationsCategory · further specificity requiredE09.3Drug or chemical induced diabetes mellitus with ophthalmic complicationsCategory · further specificity requiredE09.4Drug or chemical induced diabetes mellitus with neurological complicationsCategory · further specificity requiredE09.5Drug or chemical induced diabetes mellitus with circulatory complicationsCategory · further specificity requiredE09.6Drug or chemical induced diabetes mellitus with other specified complicationsCategory · further specificity requiredE09.8Drug or chemical induced diabetes mellitus with unspecified complicationsBillable / specificE09.9Drug or chemical induced diabetes mellitus without complicationsBillable / specificOfficial titles and instructions are preserved in their source language. Official sources ↗
Excludes 1 · drug or chemical induced diabetes mellitus (E09.-)
Excludes 1 · drug or chemical induced diabetes mellitus (E09.-)
Excludes 1 · drug or chemical induced diabetes mellitus (E09.-)
Excludes 1 · drug or chemical induced diabetes mellitus (E09.-)
Excludes 2 · diabetes with hyperosmolarity (E08, E09, E11, E13 with final characters .00 or .01)
Use additional code · from categories E08, E09 and E13 to further identify any manifestation
Use additional code · from categories E08, E09 and E13 to further identify any manifestation